198
Participants
Start Date
June 6, 2018
Primary Completion Date
November 9, 2020
Study Completion Date
March 28, 2023
AJM300
AJM300 film-coated tablets.
Placebo
Placebo matched to AJM300 tablets.
AJM300/CT3 trial site 41, Nagoya
AJM300/CT3 trial site 57, Nagoya
AJM300/CT3 trial site 63, Nagoya
AJM300/CT3 trial site 9, Toyoake
AJM300/CT3 trial site 33, Toyohashi
AJM300/CT3 trial site 42, Toyota
AJM300/CT3 trial site 39, Hirosaki
AJM300/CT3 trial site 49, Hirosaki
AJM300/CT3 trial site 11, Kashiwa
AJM300/CT3 trial site 51, Kashiwa
AJM300/CT3 trial site 73, Sakura
AJM300/CT3 trial site 54, Urayasu
AJM300/CT3 trial site 81, Matsuyama
AJM300/CT3 trial site 53, Kurume
AJM300/CT3 trial site 24, Tikushino
AJM300/CT3 trial site 55, Isesaki
AJM300/CT3 trial site 35, Fukuyama
AJM300/CT3 trial site 18, Asahikawa
AJM300/CT3 trial site 26, Asahikawa
AJM300/CT3 trial site 2, Sapporo
AJM300/CT3 trial site 3, Sapporo
AJM300/CT3 trial site 4, Sapporo
AJM300/CT3 trial site 79, Akashi
AJM300/CT3 trial site 34, Kobe
AJM300/CT3 trial site 64, Nishinomiya
AJM300/CT3 trial site 82, Kasama
AJM300/CT3 trial site 75, Tsukuba
AJM300/CT3 trial site 19, Morioka
AJM300/CT3 trial site 16, Takamatsu
AJM300/CT3 trial site 12, Kamakura
AJM300/CT3 trial site 14, Sagamihara
AJM300/CT3 trial site 32, Sagamihara
AJM300/CT3 trial site 13, Yokohama
AJM300/CT3 trial site 6, Yokohama
AJM300/CT3 trial site 47, Tsu
AJM300/CT3 trial site 46, Yokkaichi
AJM300/CT3 trial site 45, Sendai
AJM300/CT3 trial site 50, Sendai
AJM300/CT3 trial site 78, Sendai
AJM300/CT3 trial site 22, Nagaoka
AJM300/CT3 trial site 15, Kurashiki
AJM300/CT3 trial site 70, Kurashiki
AJM300/CT3 trial site 77, Higashiosaka
AJM300/CT3 trial site 76, Sayama
AJM300/CT3 trial site 10, Takatsuki
AJM300/CT3 trial site 40, Ageo
AJM300/CT3 trial site 5, Ageo
AJM300/CT3 trial site 72, Tokorozawa
AJM300/CT3 trial site 17, Hamamatsu
AJM300/CT3 trial site 60, Ashikaga
AJM300/CT3 trial site 29, Shimotsuga
AJM300/CT3 trial site 71, Utsunomiya
AJM300/CT3 trial site 61, Bunkyo
AJM300/CT3 trial site 68, Bunkyo
AJM300/CT3 trial site 59, Chiyoda City
AJM300/CT3 trial site 30, Chūō
AJM300/CT3 trial site 31, Hachiōji
AJM300/CT3 trial site 56, Minato
AJM300/CT3 trial site 66, Minato
AJM300/CT3 trial site 80, Mitaka
AJM300/CT3 trial site 38, Shinagawa
AJM300/CT3 trial site 21, Shinjuku
AJM300/CT3 trial site 52, Shinjuku
AJM300/CT3 trial site 8, Shūnan
AJM300/CT3 trial site 23, Kofu
AJM300/CT3 trial site 44, Chiba
AJM300/CT3 trial site 43, Fukuoka
AJM300/CT3 trial site 58, Fukuoka
AJM300/CT3 trial site 69, Fukuoka
AJM300/CT3 trial site 67, Gifu
AJM300/CT3 trial site 28, Hiroshima
AJM300/CT3 trial site 36, Hiroshima
AJM300/CT3 trial site 74, Hiroshima
AJM300/CT3 trial site 62, Kyoto
AJM300/CT3 trial site 7, Kyoto
AJM300/CT3 trial site 48, Nagasaki
AJM300/CT3 trial site 65, Okayama
AJM300/CT3 trial site 1, Osaka
AJM300/CT3 trial site 37, Ōita
AJM300/CT3 trial site 20, Saga
AJM300/CT3 trial site 25, Saga
AJM300/CT3 trial site 27, Toyama
Collaborators (1)
Kissei Pharmaceutical Co., Ltd.
INDUSTRY
EA Pharma Co., Ltd.
INDUSTRY